Here are relevant reports on : remanufactured-medical-devices-market
-
Leak Testing Market by Offering (Hardware, Software, Services), Equipment Type (Fixed, Portable), Vertical (Medical Devices, Pharmaceuticals, Automotive, Oil & Gas, Food & beverages, Consumer Electronics) and Region – Global Forecast 2024 to 2030
The key players ATEQ Corporation (France), INFICON (Switzerland), Drägerwerk (Germany), Honeywell International (US), Emerson Electric (US), TASI Group (US), MSA Safety (US), SGS SA (Switzerland), Uson (US), Testo (Germany), Vacuum Instruments (US), CETA TESTSYSTEME (Germany), Helium Leak Testing, (US), Pfeiffer Vacuum (Germany) and LACO Technologies (US).
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Radioisotope Identification Devices Market by Technology (Personal, Handheld, Fixed, Spectroscopic), Application (Homeland Security, Nuclear Power Plant, Medical, Environmental, CBRN), End User (Government, Hospital, Academia, Industrial) - Global Forecast to 2031
The global radioisotope identification devices market is projected to reach USD 2.85 billion by 2031, growing at a CAGR of 6.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Hydrophilic Coating Market by Substrate (Polymers, Glass/Ceramics, Metals, Nanoparticles), End User (Medical Devices, Optics, Automotive, Aerospace, Marine), and Region (APAC, North America, Europe, MEA, South America) - Global Forecast to 2027
The hydrophilic coating market is expected to grow from USD 16.8 billion in 2022 to USD 22.5 billion by 2027, at a CAGR of 6.0% during the forecast period. Major players operating in the hydrophilic coating include Hydromer, Inc (US), Harland Medical Systems, Inc (US), Surmodics, Inc (US), Koninklijke DSM NV (Netherlands), Biocoat, Inc (US), Aculon, Inc (US), AST Products, Inc (US), AdvanSource Biomaterials Corporation (US), Surface Solutions Group, LLC (US), Teleflex, Inc (US), and others.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Flow Bubble Sensor Market Size, Share & Trends by Ultrasonic, Optical, Capacitive, Medical Devices, Pharmaceutical Research, Industrial Automation - Global Forecast to 2032
The global flow bubble sensor market reached USD 280 million in 2025 and is projected to expand to USD 567.8 million by 2032, representing a compound annual growth rate (CAGR) of 10.2% from 2026 through 2032. This robust expansion is driven by accelerating adoption of microfluidic technologies in biomedical applications, rising demand for precision fluid control in pharmaceutical manufacturing, and expanding automation across industrial sectors.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Selective Laser Sintering Equipment Market by Material (Metal, and Nylon), Application (Tooling, heavy equipment & machinery, and Robotics), Industry (Consumer Goods, Automotive, Medical Devices), Laser Type, and Geography - Global Forecast to 2035
The global Selective Laser Sintering Equipment Market projected through 2035. It examines market segmentation by material application industry laser type and geography highlighting the growing use of metal and nylon in tooling heavy equipment robotics consumer goods automotive and medical devices. The discussion covers technological innovations in laser systems and material development that enhance production speed precision and part performance. Regional insights emphasize strong adoption in North America and Europe with rapid growth in Asia Pacific driven by industrial expansion and technological investments. The article explores key drivers such as rapid prototyping lightweight component production and Industry 4.0 integration. It concludes with a future outlook that underscores digital manufacturing smart factory integration and material advancements as major factors shaping the market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Biocompatible Coatings Market by Type (Antibacterial, hydrophilic), Material (Polymer, Ceramics, Metal), End-Use Industry (Healthcare, Food & Beverage, Medical Devices), & Region (APAC, Europe, North America, MEA & SA) - Global Forecast to 2028
The biocompatible coatings market is expected to grow from USD 14.6 billion in 2022 to USD 29.7 billion by 2028, at a CAGR of 12.4% during the forecast period. Major players operating in the global biocompatible coatings market are SurModics, Inc. (US), DSM Biomedical (US), Hydromer Inc. (US), Covalon Technologies Ltd. (Canada), Hemoteq AG (Germany), and Others.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Top 10 Medical Devices Market – (Point of Care Diagnostics, Hemodialysis, Minimally Invasive Surgery, Cataract & Ocular Lens, Patient Monitors) – Global Trends, Developments and Forecasts up till 2015
The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry
- Published: June 2011
- Price: $ 4950
- TOC Available:
-
Dermatology Devices Market by Type (Diagnostic (Dermatoscopes, Microscopes), Treatment (Laser, Cryotherapy), Application (Diagnostic, Medical Therapeutic, Aesthetic Therapeutic), Technology (Light), End User (Hospital) & Region - Global Forecast to 2031
The global dermatology devices market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 13.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)
The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.
- Published: August 2010
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
